Innophos Investments Holdings, Inc. manufactures specialty phosphates. The company's products include purified phosphoric acid and its downstream phosphate derivatives. The products serve food and beverage, consumer products, pharmaceutical, and nutritional supplements industries and are also used in industrial applications. The company is based in Cranbury, New Jersey. Innophos Investments Holdings, Inc. operates as a subsidiary of Innophos Holdings Inc.
259 Prospect Plains Road
Cranbury, NJ 08512-3717
Innophos Investments Holdings, Inc. and Innophos, Inc. Enter into First Amendment to Credit Agreement
Dec 23 14
On December 18, 2014, Innophos Holdings, Inc., its wholly owned subsidiaries Innophos Investments Holdings, Inc. and Innophos, Inc., as Subsidiary Borrowers, and its wholly owned subsidiaries AMT Labs, Inc., Kelatron Corporation, Woody IV, LLC, Triarco Industries, LLC and Chelated Minerals International, LLC, as Guarantors (each a company and collectively, the companies), entered into a First Amendment to Credit Agreement with a group of lenders including Wells Fargo Bank, National Association, as administrative agent. The Amendment amends that certain Amendment and Restated Credit Agreement, dated as of December 21, 2012, between the Companies and the Lenders. The Amendment deletes the requirement that Restricted Payments be deducted from the Consolidated EBITDA for purposes of determining the Fixed Charge Coverage Ratio. The Amendment provides the companies with additional flexibility to make certain Restricted Payments (as defined in the Credit Agreement), including the repurchase by the company of its stock, provided that the Companies satisfy certain financial requirements. These requirements include, after giving effect to Restricted Payments in question: (a) maintenance of the following consolidated ratios: (i) Total Leverage Ratio less than or equal to 2.50 to 1.00; (ii) Senior Leverage Ratio less than or equal to 2.00 to 1.00; and (iii) Fixed Charge Coverage Ratio greater than or equal to 1.25 to 1.00; and (b) Accessible Borrowing Availability of at least $25 million. As of the close of the last reporting period under the Credit Agreement (September 30, 2014), the company's Total Leverage Ratio, Senior Leverage Ratio and Fixed Charge Coverage Ratio calculated in accordance with the Credit Agreement were 0.91, 0.91 and 3.74 to 1.00, respectively, and, at the date of entering into the Amendment, the Accessible Borrowing Availability was approximately $188 million.